Search Results - Boss, Anders

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Coverage of Prandial Insulin Requirements by Means of an Ultra-Rapid-Acting Inhaled Insulin

    Coverage of Prandial Insulin Requirements by Means of an Ultra-Rapid-Acting Inhaled Insulin by Boss, Anders H., Petrucci, Richard, Lorber, Daniel

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin

    Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin by Heinemann, Lutz, Baughman, Robert, Boss, Anders, Hompesch, Marcus

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes

    Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes by Rave, Klaus, Heise, Tim, Heinemann, Lutz, Boss, Anders H.

    Published 2008
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin

    Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin by Levin, Philip A, Heinemann, Lutz, Boss, Anders, Rosenblit, Paul D

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes

    Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes by Sambamoorthi, Usha, Garg, Rahul, Deb, Arijita, Fan, Tao, Boss, Anders

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK

    Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in... by Roborel de Climens, Aude, Pain, Emilie, Boss, Anders, Shaunik, Alka

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration Timing on Blood Sugar Profiles

    Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration... by Gautier, Thibault, Silwal, Rupesh, Saremi, Aramesh, Boss, Anders, Breton, Marc D.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens

    Rapid Acting Insulin Use and Persistence among Elderly Type 2 Diabetes Patients Adding RAI to Oral Antidiabetes Drug Regimens by Sambamoorthi, Usha, Deb, Arijita, Zhou, Steve, Garg, Rahul, Fan, Tao, Boss, Anders

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonists

    Real‐world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon‐like peptide‐1 receptor agonist... by Rosenstock, Julio, Ampudia‐Blasco, Francisco Javier, Lubwama, Robert, Peng, Xuejun Victor, Boss, Anders, Shi, Lizheng, Fonseca, Vivian

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

    Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator by Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study

    Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study by Peng, Xuejun Victor, McCrimmon, Rory J., Shepherd, Leah, Boss, Anders, Lubwama, Robert, Dex, Terry, Skolnik, Neil, Ji, Linong, Avogaro, Angelo, Blonde, Lawrence

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents

    Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents by Rosenstock, Julio, Bergenstal, Richard, DeFronzo, Ralph A., Hirsch, Irl B., Klonoff, David, Boss, Anders H., Kramer, David, Petrucci, Richard, Yu, Wen, Levy, Brian

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

    Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA by Blonde, Lawrence, Meneghini, Luigi, Peng, Xuejun Victor, Boss, Anders, Rhee, Kyu, Shaunik, Alka, Kumar, Supriya, Balodi, Sidhartha, Brulle-Wohlhueter, Claire, McCrimmon, Rory J.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabetes

    Randomized Forced Titration to Different Doses of Technosphere® Insulin Demonstrates Reduction in Postprandial Glucose Excursions and Hemoglobin A1c in Patients with Type 2 Diabete... by Tack, Cees J., Christov, Vladimir, de Galan, Bastiaan E., Derwahl, Karl-Michael, Klausmann, Gerhard, Pelikánová, Terezie, Perušičová, Jindra, Boss, Anders H., Amin, Nikhil, Kramer, David, Petrucci, Richard, Yu, Wen

    Published 2008
    Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: